Skip to content

The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study

The Treatment of Progressive Early Onset Spinal Deformities: A Multi-Center Outcome Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02299362
Acronym
GSSG
Enrollment
2602
Registered
2014-11-24
Start date
2008-10-31
Completion date
2020-02-04
Last updated
2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Spinal Deformities, Early Onset Scoliosis, Infantile Idiopathic Scoliosis, Neuromuscular Spinal Deformity, Syndromic Spinal Deformity, Thoracic Insufficiency Syndrome

Keywords

Early Onset Scoliosis, EOS, Pulmonary function, Infantile Idiopathic Scoliosis, MCGR, Magnetically controlled growing rods, Growing rods, Growth friendly spine surgery, Cast

Brief summary

The purpose of this study is to examine the treatment, both surgical and non-surgical, of patients with any form of early onset scoliosis. Such treatment may include the use of growth friendly devices that are surgically or magnetically lengthened; or the use of serial body casting or bracing, or observation. Outcomes examined will be what can be seen physically on the patient and on x-ray, as well as parent perception of how the treatment effects their child with the use of a health-related quality of life (HRQOL) questionnaire.

Detailed description

This multi-center study will evaluate the long-term clinical and radiographic outcomes of Early Onset Scoliosis (EOS) and other Early Onset Spinal and Chest Wall Deformities in a large population of patients. The study will attempt to answer the following clinical questions: 1. How do clinical parameters (e.g. height, weight, pulmonary function, incidence of complications) differ between: 1. Age groups 2. Etiologic groups 3. Treatment types including operative and non-operative methods 4. Patients who receive definitive spinal fusion versus those who do not 2. How do radiographic parameters (e.g. curve size, spinal height, thoracic dimensions, sagittal profile, pelvic parameters, spinal balance) differ between: 1. Age groups 2. Etiologic groups 3. Treatment types including operative and non-operative methods 4. Patients who receive definitive spinal fusion versus those who do not 3. How does health-related quality of life (HRQOL), using the EOSQ-24 outcomes tool, differ between: 1. Age groups 2. Etiologic groups 3. Treatment types including operative and non-operative methods 4. Patients who receive definitive spinal fusion versus those who do not 4. What demographic, clinical, radiographic, and surgical factors contribute to the incidence of complications? 5. For patients with a particular diagnosis, age and/or treatment type, what are the clinical, radiographic and HRQOL changes before and after treatment? 6. What are the mechanisms that cause rod breakage in growing rod constructs? (This study question is a collaborative research study with the U.S. Food and Drug Administration).

Interventions

None listed

Sponsors

Growing Spine Foundation
CollaboratorUNKNOWN
Growing Spine Study Group
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients of any age and any diagnosis who undergo a growth-friendly surgical procedure, including but not limited to growing rods, VEPTR, Shilla, hybrid constructs, spinal tethering and staples * Patients of any age and any diagnosis who undergo casting * Patients of any diagnosis 10 years of age and younger who undergo spinal fusion of the thoracic and/or lumbar spine * Patients of any diagnosis under 6 years of age with scoliosis curves of the thoracic and/or lumbar spine measuring \> 25 degrees. Observed and braced patients included

Exclusion criteria

* Cervical spine anomalies alone will not be included * Patient/family is unwilling to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Clinical and Radiographic18 yearsEvaluation of long-term clinical measures such as: BMI, Pulmonary functionality, incidence of complications; and radiographic outcomes (e.g. coronal spinal curvature, sagittal profile, spinal and thoracic growth, coronal and sagittal alignment.

Secondary

MeasureTime frameDescription
Patient based outcomes18 yearsEvaluation of the effect of treatment on patients and families by use of serial early-onset scoliosis questionnaire (EOSQ-24) scores during treatment. EOSQ covers the following domains: Child's Health Related Quality of Life (16 items), Family Impact (2 items) and Satisfaction (2 items).

Countries

Canada, Egypt, Ghana, Spain, Turkey (Türkiye), United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026